Abstract
The activities of iron chelators (deferoxamine, deferiprone, Apo6619, and VK28) were evaluated against type strains of Acinetobacter baumannii, Pseudomonas aeruginosa, Staphylococcus aureus, Klebsiella pneumoniae, and Escherichia coli. Deferiprone, Apo6619, and VK28 each inhibited growth in standard and RPMI tissue culture medium, while deferoxamine had no effect. Additionally, time-kill assays revealed that VK28 had a bacteriostatic effect against S. aureus. Therefore, these newly developed iron chelators might provide a nontraditional approach for treatment of bacterial infections. Copyright © 2012 American Society for Microbiology. All Rights Reserved.
Cite
CITATION STYLE
Thompson, M. G., Corey, B. W., Si, Y., Craft, D. W., & Zurawski, D. V. (2012). Antibacterial activities of iron chelators against common nosocomial pathogens. Antimicrobial Agents and Chemotherapy, 56(10), 5419–5421. https://doi.org/10.1128/AAC.01197-12
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
